Bill
Bill > HB116
MD HB116
MD HB116Public Health - Correctional Services - Opioid Use Disorder Examinations and Treatment
summary
Introduced
01/18/2019
01/18/2019
In Committee
04/03/2019
04/03/2019
Crossed Over
03/18/2019
03/18/2019
Passed
04/06/2019
04/06/2019
Dead
Signed/Enacted/Adopted
05/13/2019
05/13/2019
Introduced Session
2019 Regular Session
Bill Summary
Requiring local correctional facilities to conduct an assessment of the mental health and substance use status of each inmate using evidence-based screenings and assessments to determine if a certain diagnosis is appropriate and if medication-assisted treatment for opioid addiction is appropriate; requiring each local correctional facility to make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders; etc.
AI Summary
This bill requires local correctional facilities to conduct assessments of inmates' mental health and substance use status, including for opioid use disorder, within 24 hours of incarceration. It mandates that medication-assisted treatment for opioid use disorder be made available to inmates for whom it is appropriate, and requires facilities to maintain the capacity to possess, dispense, and administer such medications. The bill also establishes a medication-assisted treatment program in the Baltimore Pretrial Complex and requires reporting on various metrics related to the diagnosis and treatment of opioid use disorder among inmates.
Committee Categories
Budget and Finance, Justice
Sponsors (3)
Last Action
Approved by the Governor - Chapter 532 (on 05/13/2019)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...